Multiple Sclerosis

Jan 03, 2023

Gilead Buys Out Rights to Cancer Therapy from Jounce for USD 67 Million Gilead Sciences must have liked what it saw in a two-year-old collaboration with Jounce Therapeutics for CCR8-targeting cancer immunotherapy because the company has just agreed to own the program fully. The drug in question, GS-1811 (formerl...

Jul 05, 2022

FDA Grants Orphan Drug Designation to Evorpacept for AML ALX Oncology Holdings announced that the U.S. Food and Drug Administration had granted orphan drug designation to Evorpacept, a next-generation CD47 blocker, for treating patients with acute myeloid leukemia (AML). Acute Myeloid Leukemia (AML) is an agg...

May 12, 2022

Abbott Receives Regulatory Approval from US FDA for Alinity™ m STI Assay On May 04, 2022, the US Food and Drug Administration (FDA) granted the regulatory approval to Alinity™ m STI Assay developed by Abbott which is capable of simultaneously detecting and differentiating four common sexually trans...

Nov 05, 2020

FDA nods Boston Scientific's paclitaxel-coated Ranger balloon for peripheral artery disease Boston Scientific has received the FDA approval for its Ranger paclitaxel-coated balloon, designed to restrict a patient's systemic exposure to the chemotherapy used to reduce the closure of reopened arteries. The slim...

Oct 19, 2020

Neurodegenerative diseases affect millions of people worldwide. And with the world demographics getting older, it is apt to foretell that the burden of neurodegenerative disorders is expected to mount. With advances in medical technology, the life expectancy of people has drastically increased, reeling people to an...

Aug 04, 2020

MorphoSys, Incyte gets an early FDA nod for Monjuvi, an alternative to CAR-T for B-cell malignancies MorphoSys and Incyte announced the US FDA approval under accelerated approval for their treatment Monjuvi in combination with lenalidomide for adult patients with relapsed or refractory diffuse large B-cell lymp...

May 21, 2020

CanSino adds mRNA with Precision NanoSystems  CanSino Biologics is already evaluating a recombinant coronavirus vaccine in China. However, it is adding the mRNA to COVID-19 vaccine through a licensing agreement with Precision NanoSystems. The partners will work on an mRNA nanoparticle vaccine for COVID-1...

Jan 08, 2020

Cannabis sativa or Cannabis indica is commonly known as Medical marijuana or cannabis (cannabinoids) are prescribed by physicians to their patients, to treat diseases, conditions or to relieve pain or symptoms. As per the National Institute of Health, Marijuana or cannabis is used for the treatment of ailments for ...

May 30, 2019

Multiple Sclerosis Multiple Sclerosis is an unpredictable, autoimmune disease that affects the central nervous system. In this disease, the body's own immune system produces cells and proteins (antibodies), which attack the fatty substance,myelin that protects the nerve fibres. So, 30 May 2019 is globally obser...

Apr 17, 2019

Multiple Sclerosis is an unpredictable, autoimmune disease that affects the central nervous system, disrupting the transfer of information within, or between the brain and body. It causes the body’s immune system to produce cells and proteins (antibodies) that attack the fatty substance, myelin, which is responsibl...